Q2 2026 Healthcare AI Trends: Rapid Adoption, Uneven Maturity, New Priorities

ScienceSoft combines a healthcare IT consulting practice with AI engineering skills to help healthcare organizations introduce AI into their clinical and administrative workflows. Drawing on our Q2 2026 Healthcare IT Market Watch and recent industry developments, we identified five shifts that may shape healthcare AI adoption over the next 12–24 months.

Key takeaways:

• Healthcare AI adoption is accelerating, but maturity remains uneven. Health systems are adopting more AI solutions, physician use is already widespread, and payers remain further behind.
• Ambient AI is moving beyond documentation. AI scribes begin to use chart context, update EHR records, and support claims and other downstream workflows.
• Administrative AI may attract the next major wave of investment. Prior authorization, medical coding, claims processing, and support for health plan members offer clearer metrics and repeatable business cases.
• Healthcare AI is narrowing around workflows instead of specialties. The strongest tools focus on a defined user, decision, and permitted action.
• Healthcare AI is shifting from isolated tools to portfolio design. As AI becomes embedded across healthcare software, providers need shared architecture, governance, and evaluation rules.

 

Healthcare AI adoption is accelerating, but maturity remains uneven

AI adoption is expanding across healthcare, but organizations are progressing at different speeds. In a survey of 120 US health systems, Eliciting Insights reported a 67% year-over-year increase in health systems implementing or planning to implement three or more AI solutions.

McKinsey found that generative AI had been implemented by 52% of surveyed clinical care organizations and 34% of surveyed payers. Adoption of multiagent systems was still limited, at 18% and 10%, respectively. At the individual level, an American Medical Association survey found that more than 81% of responding US physicians used AI professionally. The most common applications involved research summarization and clinical documentation.

The surveys capture different parts of the market, but together they show that AI adoption is broadening unevenly across organizations and technologies.

Healthcare may be known for slow technology adoption, but AI is moving differently. Strong pressure to reduce documentation and administrative work is pushing clinicians and departments to adopt tools before many organizations have a shared approach.

Ambient AI has won documentation. Now it is expanding beyond the note

Clinical note-taking and ambient listening remain the most widely adopted AI use category among the surveyed US health systems. An Eliciting Insights survey of 120 health systems found that 68% used AI for ambient listening and clinical note-taking. The category is no longer defined only by its ability to turn a conversation into a draft note, however.

Newer products are beginning to use patient chart context, populate structured EHR fields, detect documentation inconsistencies, and remain active throughout the documentation workflow. SPRY’s Agentic Scribe, designed for rehabilitation therapy, illustrates this shift. The company says some clinics reduced documentation time by up to 75% and reported revenue growth of 20–30% within 90 days.

Industry discussions increasingly distinguish between ambient AI as an EHR feature and ambient AI as a platform. The first mainly reduces documentation effort. The second uses the resulting clinical information to support coding, claims, quality checks, and decision-making. The next phase of ambient AI adoption will be shaped less by transcription accuracy alone and more by how safely documentation can be connected to the rest of the encounter.

I see ambient scribes as more than a point solution. For many providers, they are the first large-scale AI project. Once an organization has worked out EHR integration, clinical review, and governance for a scribe, it can reuse much of that experience for other AI tools.

I think the line between an ambient scribe and a broader workflow platform is crossed when the tool starts doing more than preparing a note for review. Once it uses information from the patient record, fills in EHR fields, checks documentation quality, or passes data into claims workflows, it becomes part of the organization’s clinical infrastructure.

That is where providers need to look beyond transcription accuracy and minutes saved. They should assess what the tool can access and change, how clinicians review its work, and whether its actions are traceable. A small error in a draft note may be caught during review. If it reaches coding or claims, it can lead to rework, delays, or incorrect billing.

Over the next year or two, I expect the ambient market to split. Some products will remain convenient EHR features focused on documentation. Others will develop into platforms that support much more of the encounter. The second group may create greater value, but providers will need to govern them very differently.

While clinical AI gets the headlines, administrative AI will probably get the budgets

Clinical use cases continued to dominate AI announcements in Q2 2026. New tools supported nursing, oncology outreach, clinical-trial matching, clinical reasoning, and medical imaging. Yet survey data suggests that administrative efficiency may become the larger near-term investment priority.

In a McKinsey survey of 150 healthcare leaders, 87% identified administrative efficiency as an area with high potential for generative AI, while 76% said the same about multiagent systems. The category included administrative, financial, and operational workflows. Eliciting Insights also found that health systems are considering AI for prior authorization, appeals, coding, and denial management.

The vendor market is moving in the same direction. Emids introduced prebuilt agentic workflows for prior authorization, claims intake, enrollment, and support for health plan members. UnitedHealthcare also launched Avery, an AI companion for member support. More broadly, parent company UnitedHealth Group says it plans to invest $1.6 billion in AI in 2026.

Clinical AI naturally gets more attention because the use cases are easier to explain and often more impressive. But when a healthcare organization decides where to invest first, the calculation is usually much more practical. Administrative workflows have known volumes, visible backlogs, and measurable costs. It is easier to show that a tool reduced processing time or prevented avoidable rework than to prove that it improved a complex clinical decision.

I would still be careful with the idea that these workflows are easy to automate. Prior authorization work involves a large number of exceptions, changing payer rules, and data coming from several systems. An agent may handle the predictable part of the process, but it also needs to recognize when a case no longer fits the standard path and hand it over with enough context for a person to continue.

I think that the first large-scale healthcare agent deployments will be concentrated in administrative and financial workflows. Clinical agents will continue to attract more attention, but administrative agents are more likely to produce the repeatable business case organizations need before they scale.

Healthcare AI is narrowing around workflows, not just specialties

Healthcare AI products are becoming more specialized, though specialty labels alone do not explain the trend. New tools increasingly focus on a particular role and workflow.

Chart Chat for Nursing, for example, is embedded in the EHR and lets nurses retrieve and interpret information from patient records, clinical notes, and hospital policies. Atlantic Health’s oncology agents handle a far narrower task: confirming colonoscopy appointments, directing patients to preparation materials, and answering approved questions. In the first 30 days, the agents reduced staff call time by 38%.

Other Q2 developments followed the same logic. Advocate Health began testing an AI system that screens oncology patients for relevant clinical trials, with clinicians reviewing matches before enrollment. CMR-CLIP was trained specifically to interpret cardiac MRI scans by connecting imaging data with radiology reports.

I would not evaluate these tools mainly by asking whether they are built for oncology, nursing, or rehabilitation. A specialty is still a very broad environment. What matters more is whether the tool has a clear purpose and scope.

“AI for oncology” can mean anything from patient outreach to treatment recommendations. An agent that confirms a colonoscopy appointment and answers a limited set of approved questions is much easier to test and control. The same applies to a copilot that screens patients against trial criteria but leaves the final eligibility decision to a clinician.

In the near term, narrow tools will perform better than broad healthcare copilots because their behavior is easier to evaluate and their limits are clearer to users. The challenge is that providers may end up with too many separate tools. A viable approach is to use a shared technical and governance foundation, then introduce tightly bounded modules for specific roles and workflows.

Healthcare AI is shifting from standalone products to embedded capabilities

AI is becoming harder to separate from the wider healthcare technology market. In its Q1 2026 funding analysis, Rock Health stopped tracking AI companies as a distinct category because AI had become a standard capability across digital health products. US digital health companies raised $4 billion across 110 deals during the quarter.

This shift changes how healthcare organizations encounter AI. A provider may no longer procure a clearly labeled AI product. AI may arrive as part of an EHR module, analytics platform, patient engagement tool, revenue cycle application, or broader software upgrade.

As a result, AI oversight can no longer be handled product by product. Organizations need a consistent way to assess AI capabilities built into software, control access to data and workflows, monitor their performance, and understand how vendors use or retain information.

The next step in AI maturity is to establish a shared architecture and governance model for AI capabilities distributed across the technology portfolio. Without that foundation, each successful implementation may add value locally while making the overall environment harder to evaluate, integrate, and control.

Over the next two years, I expect providers to focus less on adding isolated tools and more on building an AI portfolio, with governance rules and reusable integrations.

Want to Go Deeper?

Speak with ScienceSoft's healthcare AI experts to source quotes or data for your story.

Request expert input

References

Health System Adoption of AI Solutions: February 2026 (Eliciting Insights, February 2026).

2026 Physician Survey on Augmented Intelligence (American Medical Association, March 2026).

Generative AI in Healthcare: Adoption Matures as Agentic AI Emerges (McKinsey, April 16, 2026).

SPRY Launches First AI Scribe Agent Built Natively for Rehab Therapy (SPRY, April 8, 2026).

Introducing Chart Chat for Nursing (Ambience Healthcare, April 1, 2026).

Atlantic Health Reduces Colonoscopy Screening Gaps Using Artera's AI Agents (Atlantic Health, March 30, 2026).

Advocate Health Partners with AI Startup to Connect More Cancer Patients to Clinical Trials (Advocate Health, May 27, 2026).

Emids Unveils Healthcare Agentic AI Suite Integrated with Anthropic (Emids, April 16, 2026).

UnitedHealthcare Introduces AI Companion Empowering People with Simpler Navigation, Personal Experience (UnitedHealth Group, March 26, 2026).

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy (Cleveland Clinic, May 21, 2026).

Q1 2026 Funding Overview: Capital Continues Concentrating and Four Other Market Signals (Rock Health, April 6, 2026).